3 suspended. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Suspended 3 |
Follow Thoracic Neoplasms: new trials by email Literature Review of Thoracic Neoplasms trials Research Report on Thoracic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis Prolonged glucocorticosteroid (prednisone) regimen, Short glucocorticosteroid (prednisone) regimen - Lung Neoplasm Malignant, Interstitial Lung Disease | Phase 4 | Suspended | National Institute for Tuberculosis and Lung Diseases, Poland | 85 | 2019-10-01 | 2023-02-23 |
| Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy Icotinib - Non-small Cell Lung Cancer | Phase 4 | Suspended | Betta Pharmaceuticals Co., Ltd. | 20 | 2013-02-01 | 2015-05-22 |
| Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer Erlotinib - Non-small Cell Lung Cancer Metastatic | Phase 4 | Suspended | National Guard Health Affairs | 100 | 2009-10-01 | 2016-05-13 |
Lung Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Lung Diseases, Interstitial (1) · Pneumonia (1)
Lung Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Infections (1) · Lung Neoplasms (1) · Respiratory Tract Infections (1)
Clinical Protocols (1) · Erlotinib Hydrochloride (1) · Prednisone (1) · icotinib (1)
Betta Pharmaceuticals Co., Ltd. (1) · National Guard Health Affairs (1) · National Institute for Tuberculosis and Lung Diseases, Poland (1)
China (1) · Poland (1) · Saudi Arabia (1)
Abdulrahman Jazieh, MD/MPH (1) · Hu Chengping, M.D. (1)